DeFronzo RA - Search Results

1

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl H, Ohashi S, Matsuda M, Miyazaki Y, Mahankali A, Kumar V, Pipek R, Iozzo P, Lancaster JL, Cincotta AH, DeFronzo RA. Pijl H, et al. Among authors: defronzo ra. Diabetes Care. 2000 Aug;23(8):1154-61. doi: 10.2337/diacare.23.8.1154. Diabetes Care. 2000. PMID: 10937514 Clinical Trial.

2

Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System.

Daniele G, Iozzo P, Molina-Carrion M, Lancaster J, Ciociaro D, Cersosimo E, Tripathy D, Triplitt C, Fox P, Musi N, DeFronzo R, Gastaldelli A. Daniele G, et al. Diabetes. 2015 Oct;64(10):3406-12. doi: 10.2337/db14-1718. Epub 2015 Jun 26. Diabetes. 2015. PMID: 26116695 Free PMC article. Clinical Trial.

3

In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.

Bonora E, Bonadonna RC, Del Prato S, Gulli G, Solini A, Matsuda M, DeFronzo RA. Bonora E, et al. Among authors: defronzo ra. Diabetes. 1993 May;42(5):764-72. doi: 10.2337/diab.42.5.764. Diabetes. 1993. PMID: 8482434

4

Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.

Pendergrass M, Koval J, Vogt C, Yki-Jarvinen H, Iozzo P, Pipek R, Ardehali H, Printz R, Granner D, DeFronzo RA, Mandarino LJ. Pendergrass M, et al. Among authors: defronzo ra. Diabetes. 1998 Mar;47(3):387-94. doi: 10.2337/diabetes.47.3.387. Diabetes. 1998. PMID: 9519744

5

Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Matsuda M, DeFronzo RA. Matsuda M, et al. Among authors: defronzo ra. Diabetes Care. 1999 Sep;22(9):1462-70. doi: 10.2337/diacare.22.9.1462. Diabetes Care. 1999. PMID: 10480510

6

Altered hypothalamic function in response to glucose ingestion in obese humans.

Matsuda M, Liu Y, Mahankali S, Pu Y, Mahankali A, Wang J, DeFronzo RA, Fox PT, Gao JH. Matsuda M, et al. Among authors: defronzo ra. Diabetes. 1999 Sep;48(9):1801-6. doi: 10.2337/diabetes.48.9.1801. Diabetes. 1999. PMID: 10480611

7

Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Diabetes Care. 2001 Apr;24(4):710-9. doi: 10.2337/diacare.24.4.710. Diabetes Care. 2001. PMID: 11315836 Clinical Trial.

8

Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.

Miyazaki Y, DeFronzo RA. Miyazaki Y, et al. Among authors: defronzo ra. Diabetes Obes Metab. 2008 Dec;10(12):1204-11. doi: 10.1111/j.1463-1326.2008.00880.x. Epub 2008 May 12. Diabetes Obes Metab. 2008. PMID: 18476983

9

Effects of angiotensin-converting enzyme inhibitors, Ca2+ channel antagonists, and alpha-adrenergic blockers on glucose and lipid metabolism in NIDDM patients with hypertension.

Giordano M, Matsuda M, Sanders L, Canessa ML, DeFronzo RA. Giordano M, et al. Among authors: defronzo ra. Diabetes. 1995 Jun;44(6):665-71. doi: 10.2337/diab.44.6.665. Diabetes. 1995. PMID: 7789631

10

Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects.

Eldor R, Daniele G, Huerta C, Al-Atrash M, Adams J, DeFronzo R, Duong T, Lancaster J, Zirie M, Jayyousi A, Abdul-Ghani M. Eldor R, et al. Diabetes Care. 2016 Oct;39(10):1804-10. doi: 10.2337/dc15-2706. Epub 2016 Aug 3. Diabetes Care. 2016. PMID: 27489336 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

669 results

Search Page